Urenco USA Achieves First Commercial LEU+ Production at New Mexico Facility
Urenco USA has commenced commercial production of low-enriched uranium-plus, known as LEU+, at its National Enrichment Facility in New Mexico — a milestone that broadens the enrichment product slate available to nuclear fuel buyers in the United States and internationally.
The US Nuclear Regulatory Commission granted authorisation in September 2025 for the facility to enrich uranium up to 10% U-235. All gas centrifuge cascades at the plant are now licensed to produce LEU+, enabling the full site capacity to be directed toward the higher-assay product when required.
What is LEU+ and Why Does It Matter?
Conventional commercial reactor fuel is fabricated using low-enriched uranium enriched to between 3% and 5% U-235. LEU+ occupies the band between 5% and 10% U-235, sitting above standard LEU but below the high-assay low-enriched uranium (HALEU) threshold of 10–20% U-235.
For existing light water reactors, LEU+ fuel can support longer operating cycles, reducing the frequency of refuelling outages and associated operations and maintenance costs. Several advanced reactor designs currently under development are also specified to use LEU+ fuel. Additionally, LEU+ can serve as a feedstock for the production of HALEU, which is required by a further subset of next-generation reactor technologies.
Capacity Expansion Under Way
Urenco USA is currently installing an additional 700,000 separative work units (SWU) of centrifuge enrichment capacity at the New Mexico site as part of a broader programme to grow its total US enrichment output to more than 7 million SWU over the next decade.
Beyond the ongoing expansion, the company has announced plans for an entirely new enrichment plant at the same location, sized at 2.1 million SWU. Construction is scheduled to begin in 2029, with the first centrifuge cascades expected to enter production in 2032 and further cascades to be commissioned through to 2036. The new plant will also be capable of producing LEU+, extending the higher-assay supply base as demand from both conventional and advanced reactor customers grows.
Industry Context
The commencement of LEU+ commercial production represents a concrete step in efforts to develop a reliable domestic enrichment supply chain in the United States, particularly as interest in advanced reactor deployment accelerates. Having a licensed, operating source of LEU+ reduces a key fuel-supply dependency for reactor developers and utilities planning longer fuel cycles or transitioning to next-generation designs.